CLINICAL SKILLS FOR PHARMACISTS A Patient-Focused Approach E D I T I O N 3 Karen J. Tietze, PharmD Professor of Clinical Pharmacy University of the Sciences in Philadelphia Philadelphia, Pennsylvania 3251 Riverport Lane St. Louis, Missouri 63043 CLINICAL SKILLS FOR PHARMACISTS: A PATIENT-FOCUSED APPROACH 978-0-3230-7738-5 Copyright © 2012, 2004, 1997 by Mosby, Inc., an affiliate of Elsevier Inc. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher. Details on how to seek permission, further information about the Publisher’s permissions policies and our arrangements with organizations such as the Copyright Clearance Center and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions. This book and the individual contributions contained in it are protected under copyright by the Publisher (other than as may be noted herein). Notice Knowledge and best practice in this field are constantly changing. As new research and experience broaden our understanding, changes in research methods, professional practices, or medical treatment may become necessary. Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds, or experiments described herein. In using such information or methods they should be mindful of their own safety and the safety of others, including parties for whom they have a professional responsibility. With respect to any drug or pharmaceutical products identified, readers are advised to check the most current information provided (i) on procedures featured or (ii) by the manu- facturer of each product to be administered, to verify the recommended dose or formula, the method and duration of administration, and contraindications. It is the responsibility of practitioners, relying on their own experience and knowledge of their patients, to make diagnoses, to determine dosages and the best treatment for each individual patient, and to take all appropriate safety precautions. To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors, assume any liability for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Library of Congress Cataloging-in-Publication Data Tietze, Karen J. Clinical skills for pharmacists : a patient-focused approach / Karen J. Tietze. -- 3rd ed. p. ; cm. Includes bibliographical references and index. ISBN 978-0-323-05485-0 (alk. paper) 1. Pharmacy. 2. Pharmacy--Practice. 3. Communication in pharmacy. I. Title. [DNLM: 1. Pharmaceutical Services. 2. Pharmacists. 3. Pharmacy--methods. 4. Professional- Patient Relations. QV 737] RS91.T54 2011 615’.1--dc22 Acquisitions Editor: Kellie White Developmental Editor: Kelly Milford Publishing Services Manager: Catherine Jackson Project Manager: Sara Alsup Design Direction: Teresa McBryan Printed in Last digit is the print number: 9 8 7 6 5 4 3 2 1 To my students Preface I n the preface to the first edition of Clinical Skills for Pharmacy, was updated to reflect the current state Pharmacists, I described how the book was developed, of pharmacy practice, including medication therapy the organization, structure, and format of the book, as management, medication reconciliation, and pharmacy- well as my hopes for the book. I ended the preface by based immunization. Cultural diversity and telecommu- stating that the book was a work in progress and that all nication were added to Chapter 2, Communication Skills suggestions for improvement were welcome. Although for the Pharmacist. The immunization history as a com- I thought the book was unique, and hoped it would ponent of the medication history, examples illustrating find a useful niche within the profession, I was unsure each component of the medication history, and a medi- of its acceptance. I have been quite surprised by the cation history checklist were added to Chapter 3, Taking overwhelmingly positive response the first two editions Medication Histories. Chapter 4, Physical Assessment Skills, of the book have elicited. Although my students delight was expanded and reorganized to provide more contextu- in pointing out the occasional typographical error or al context for pharmacists, including checklists for assess- inconsistency, feedback regarding the style and content ing skills performance. A new biomarker section was has been consistently positive. The book has found a added to Chapter 5, Review of Laboratory and Diagnostic niche as a unique compilation of skill-related topics, and Tests. Examples illustrating each component of the struc- is complementary to clerkship manuals and physical tured patient case were added to Chapter 6, The Patient assessment, pharmacotherapeutics, and ethics textbooks. Case Presentation. More examples and guidance were The third edition has been completely updated. The added to Chapter 7, Therapeutics Planning, and Chapter book is now in color and in a larger format. More than 8, Monitoring Drug Therapies. Chapter 9, Researching and 100 images (figures, photographs, illustrations), most in Providing Drug Information, was completely updated and color, were added to this edition. A list of chapter acro- example drug information questions, including answer, nyms was added to the book, for easy reference. Also new source, and comments were added. A discussion of con- to the third edition are chapter-specific application exer- temporary pharmacy-related ethical issues, including cises. Located at the end of each chapter, the application conscientious objection, and issues related to confiden- exercises are best completed in small groups, though they tiality and research were added to Chapter 10, Ethics in can be completed individually. Pharmacy and Health Care. Approximately one-third of the book content is new. This book remains a work in progress. Comments and Basic clinical pharmacy skills remain the focus of the suggestions for improvement are always welcome. book, but the skills have been expanded to facilitate longitudinal development throughout the pharmacy cur- Karen J. Tietze riculum. Chapter 1, Introduction: The Practice of Clinical vii Acknowledgments I t is impossible to individually thank all those who Developmental Editor; Laura MacAdam, Developmental contributed to the development of this book. I hope Editor; Jennifer Roche, Acquisitions Editor; and Jennifer that my global thanks reach everyone involved in the Furey, Production Editor. Their guidance and enthusiasm development and publication of this book. I thank all were invaluable. The editors for the second edition, Kellie my students who continue to teach me how best to learn White, Editor, and Kim Fons, Senior Developmental clinical pharmacy skills. I also thank my colleagues at Editor had a “can do” attitude and never-failing enthu- the Philadelphia College of Pharmacy, University of the siasm for the book that kept me motivated and on track Sciences whose moral support during the developmental with a very ambitious production timeline. For the third stages of the book and the writing of the second and edition, I was very privileged to work once again with third editions of the book was invaluable. Kellie White, Executive Editor. Kellie has an intuitive Special thanks to the following individuals who pro- understanding of what this book is all about; it was great vided detailed reviews of one or more chapters when the fun to plan out the changes for the third edition of the first edition of the book was being developed: Jerry L. book with her. Other members of the editorial team for Bauman, Pharm.D.; Janice A. Gaska, Pharm.D.; Arthur the third edition included Kelly Milford, Developmental I. Jacknowitz, Pharm.D.; Paul L. Ranelli, Ph.D.; and Editor, Jennifer Watrous, Senior Developmental Editor, Timothy H. Self, Pharm.D. Emily Thomson, Editorial Assistant, and Sara Alsup, I am especially indebted to Dr. Janice Gaska. Our origi- Associate Project Manager. Publishing is truly a team nal plan was to coauthor the book. We spent countless effort, and I am grateful for everyone’s support and hours planning the book before she changed careers. The patience. book reflects both of our philosophies and is much better Finally, thanks to my family for their support and than I could have created on my own. understanding of what it takes to get this type of project No book can succeed without the resources and sup- completed. port of the publisher. I have been incredibly lucky to work with very talented editors from Elsevier, Inc. My Karen J. Tietze editorial team for the first edition included Sandra Parker, viii C H A P T E R 1 Introduction: The Practice of Clinical Pharmacy LEARNING OBJECTIVES • Define pharmaceutical care and identify the four • State the eligibility requirements for pharmacist board outcomes that improve a patient’s quality of life. certification and identify the areas for which board • Define medication therapy management. certification is available. • List the three goals and five core elements of • Define residency and fellowship and differentiate them medication therapy management. with regard to length of training and mechanisms for • List the knowledge and skills needed for patient- credentialing. focused pharmacy practice. • Identify and differentiate among the various types of • State the requirements for pharmacy state licensure health care settings and environments. and relicensure. • Define health maintenance organization, point-of- • Differentiate between pharmacist board certification, service plans, and preferred provider organizations. pharmacist-specific disease-specific credentialing, • State the purpose of the medical team and identify the multidisciplinary disease-specific credentialing, and roles and responsibilities of each team member. pharmacy certificate programs in terms of eligibility and • Identify and describe unresolved health care system requirements. issues. P harmacy practice is moving toward a model that implies the integration of patient- and product-oriented integrates patient-focused care (also known as patient- pharmacy practice. centered care) and drug distribution services. To be success- Patient-focused pharmacists work closely with physi- ful, pharmacists must understand and speak the language cians and other health care professionals to provide optimal of the health care system and function in a system that patient care. Some pharmacists in traditional product- to the uninitiated is foreign and excessively complex. centered practice settings use clinical pharmacy skills in a The variety of providers, rapidly evolving types of health limited capacity, such as when they obtain a medication care delivery systems, and complexities of relationships history or triage a patient to self-care with nonprescrip- among the various heath care professionals working tion drugs. Some pharmacists have no traditional product- within the health care system add to the confusion. This centered responsibilities and instead provide full-time chapter describes patient-focused pharmacy practice and patient-focused care. Regardless of the setting and the degree the clinical environment in which patient-focused phar- to which patient-focused skills are used, patient-focused care macists function. is an integral part of the practice of pharmacy (Figure 1-1). The term pharmaceutical care is used to describe the broad-based, patient-focused responsibilities of pharma- PATIENT-FOCUSED PHARMACY PRACTICE cists (see Figure 1-1). Hepler and Strand define pharma- ceutical care as the “responsible provision of drug therapy The term clinical pharmacy historically described patient- for the purpose of achieving definite outcomes that oriented rather than product-oriented pharmacy practice. improve a patient’s quality of life.”1 The four outcomes The term clinical pharmacist was used to describe a phar- identified include the following: macist whose primary job was to interact with the health 1. Cure of disease care team, interview and assess patients, make patient- 2. Elimination or reduction of symptoms specific therapeutic recommendations, monitor patient 3. Arrest or slowing of a disease process response to drug therapy, and provide drug information. 4. Prevention of disease or symptoms Clinical pharmacists, working primarily in acute care set- Pharmaceutical care requires an expert knowledge of tings, were viewed as “drug experts”; other pharmacists therapeutics; a good understanding of disease processes; could occasionally use “clinical” skills, but they remained knowledge of drug products; strong communication focused on product management. The pharmacy profes- skills; drug monitoring, drug information, and therapeu- sion has evolved to the point that many pharmacists find tic planning skills; and the ability to assess and interpret the term clinical pharmacy redundant; the term pharmacist physical assessment findings (Figure 1-2). 1 2 Clinical Skills for Pharmacists: A Patient-Focused Approach Box 1-1 Medication Therapy Management (MTM) Core Elements • Provide a comprehensive or targeted medication therapy review • Complete and update the patient’s personal medication record (PMR) • Develop a medication-related patient-directed action plan (MAP) • Intervene and/or refer when appropriate • Document all services and interventions, communicate results of the MTM encounter, and provide appropriate follow-up Adapted from Bluml BM: Definition of medication therapy management: devel- opment of profession wide consensus. J Am Pharm Assoc 45:566-572, 2005. Figure 1-1 Patient-Focused Care in the Community Box 1-2 Pharmacist Practice Areas Pharmacy. Patient-focused care is an integral part of the practice of pharmacy in all patient care settings. (Hopper T: Mosby’s phar- Ambulatory care macy technician: Principles and practice, ed 2, St Louis, Saunders, Critical care 2007.) Drug information Geriatrics and long-term care Internal medicine and subspecialties Cardiology Endocrinology Gastroenterology Infectious disease Neurology Nephrology Obstetrics and gynecology Pulmonary disease Psychiatry Rheumatology Nuclear pharmacy Nutrition Pediatrics Pharmacokinetics Surgery SITES AND TYPES OF PRACTICE Figure 1-2 Patient Care. Patient care requires integration of Patient-focused pharmacy practice is performed every- knowledge and skills. where patients interact with the health care system, includ- ing community pharmacies, outpatient clinics, teaching and community hospitals, long-term care facilities, and Medication therapy management (MTM) services pro- home health care. Pharmacists, like other health care pro- vide pharmacists with new opportunities for direct patient fessionals, specialize in practice areas such as pediatrics, care. The Medicare Prescription Drug, Improvement, and critical care, nutrition, and cardiology (Box 1-2). Some Modernization Act of 2003 (also known as the Medicare practice areas (e.g., infectious disease, nutrition) parallel Modernization Act) established Medicare Part D.2 Medicare and are similar to traditional medical specialty and sub- Part D provides for prescription drug benefits for Medi- specialty areas. Other specialty practice areas (e.g., drug care beneficiaries, including pharmacist- provided MTM information, pharmacokinetics) are unique to pharmacy. services. MTM is defined as “a distinct service or group of services that optimize therapeutic outcomes for indi- REQUIREMENTS AND VOLUNTARY vidual patients. Medication Therapy Services are indepen- CREDENTIALING AND CERTIFICATE dent of, but can occur in conjunction with, the provision PROGRAMS of a medication product.”3 The goals of MTM services Requirements include improved medication understanding, adherence and detection of medication-related problems, includ- Licensure. To be eligible for licensure, pharmacists must ing adverse drug reactions.4 MTM services include a wide be graduates of a college of pharmacy accredited by the range of responsibilities and activities (Box 1-1). American Council on Pharmaceutical Education (ACPE) Chapter 1 Introduction: The Practice of Clinical Pharmacy 3 or from a pharmacy school approved by the state board of pharmacy. Pharmacists who graduated from foreign pharmacy schools are eligible for licensure if they have earned the Foreign Pharmacy Graduate Examination Committee (FPGEC) certification or follow other state- specific requirements. All states except California require successful completion of the North American Pharmacist Licensure Examination (NAPLEX). (California admin- isters its own licensing examination.) All states require that licensure candidates complete a specified number of internship hours, typically around 1500 hours, prior to seeking licensure. Some states allow the internship hours to be earned prior to graduation from pharmacy school; some states require that some or all of the hours be earned after graduation. Many states also require suc- cessful completion of the Multi-State Pharmacy Juris- prudence Examination (MPJE). Some states still require successful completion of a laboratory (“wet lab”) exami- nation. Licensure for authorization to administer inject- able medications (e.g., immunizations) is a separate but parallel licensing process. Relicensure. Most licensing boards require that pharma- cists earn continuing education units (CEUs) for relicen- sure. The CEUs are earned by successful participation in Figure 1-3 Pharmacist Credentials. Pharmacists are eligible for a variety of voluntary credentials. (Jupiter Images) ACPE-accredited continuing education programs (e.g., live programs and continuing education articles in pro- fessional journals). Some states require that pharmacists earn some of the CEUs by participating in specific types Table 1-1 Board of Pharmacy Specialties (BPS) of continuing education programs (e.g., live programs). Recognized Pharmacy Specialties Some states require specific content (e.g., human immu- Initial nodeficiency virus [HIV] or immunization continuing Specialty Acronym Recognition education). Nuclear Pharmacy BCNP 1978 Voluntary Credentialing and Certificate Programs Pharmacotherapy BCPS 1988 Postlicensure credentialing. Postlicensure credential- Nutrition Support Pharmacy BCNSP 1988 ing is voluntary and is available at the specialist or dis- Psychiatric Pharmacy BCPP 1992 ease level. Postlicensure credentials indicate that the Oncology Pharmacy BCOP 1996 pharmacist has additional expertise above and beyond what is required for licensure (Figure 1-3). The Council BCNP, Board Certified Nuclear Pharmacist; BCNSP, Board Certified on Credentialing in Pharmacy (CCP) defines certifica- Nutrition Support Pharmacist; BCOP, Board Certified Oncology Pharmacist; tion as “a voluntary process through which a nongov- BCPP, Board Certified Psychiatric Pharmacist; BCPS, Board Certified ernmental agency or an association grants recognition Pharmacotherapy Specialist. to an individual who has met certain predetermined qualifications specified by that organization. This formal recognition is granted to designate to the public that this the BPS6 (Table 1-1). Requirements vary by board. For individual has attained the requisite level of knowledge, example, BPS board certification requires an entry-level skill, and/or experience in a well-defined, often special- pharmacy degree (bachelor of science in pharmacy or doc- ized, area of the total discipline.”5 The term certification tor of pharmacy), an active pharmacy license, additional should not be confused with the term certificate, which experience and/or training (residency or fellowship) in is the document given to a person upon completion of the specialty area, and passage of a specialty-specific writ- a program. ten examination. Recertification is required every 7 years. Specialist credentialing. Board certification (official The BPS also recognizes additional expertise within a sub- recognition of specific knowledge and skills) is achieved specialty area by the designation “Added Qualifications in addition to state and federal professional licensure. (AQ)” (e.g., Board Certified with Added Qualifications). Some employers require board certification for specific Added Qualifications in infectious diseases pharmaco- jobs, whereas other employers reward pharmacists who therapy and cardiology pharmacotherapy are currently become board certified with additional career advance- available within the pharmacotherapy specialty practice ment opportunities and salary differentials. The Board area. The Added Qualifications designation is earned by of Pharmacy Specialties (BPS), created in 1976 by the demonstrating the additional expertise through a portfo- American Pharmacists Association (APhA), is responsible lio process (Box 1-3). for setting standards for certification and recertification Multidisciplinary disease-specific credentialing: A and for administering the certification and recertification variety of health care professionals, including pharma- proc esses. Five specialty practice areas are recognized by cists, are eligible for certification in select disease-specific 4 Clinical Skills for Pharmacists: A Patient-Focused Approach multidisciplinary certification programs (Table 1-2). program. Certificate programs are voluntary and do not Requirements are different for each program. For exam- require any additional training or experience beyond ple, the 2010 requirements for application for the Certi- that required for pharmacy licensure. ACPE certificate fied Diabetic Educator (CDE) program include a minimum programs provide at least 15 hours of programming that of 2 years of professional practice, completion of a mini- must include practice experiences to demonstrate the mum of 1000 hours of diabetes self-management edu- given professional competency. Participants are evalu- cation (DSME), completion of a minimum of 15 hours ated by a summative evaluation process. Completion of of relevant continuing education activities within the 2 a certificate program provides evidence of achievement years prior to application, and status as either a licensed of professional competencies beyond those required for clinical psychologist, registered nurse, occupational ther- pharmacy licensure. apist, optometrist, pharmacist, physical therapist, physi- Postlicensure residency and fellowship training pro- cian (MD or DO), or podiatrist, or as a registered dietitian, grams. Pharmacy graduates obtain additional experi- physician assistant, exercise physiologist, or other health ence, knowledge, and skills by completing a variety of care professional with a minimum of a master’s degree.7 residency and fellowship postgraduate training certifi- Certificate programs. In 2000, the ACPE assumed cate programs. Most residency and fellowship programs responsibility for voluntary pharmacy certificate pro- require candidates to have either entry-level or postbac- grams based on specific professional competencies (Phar- calaureate doctor of pharmacy degrees. The American macy-Based Immunization Delivery, Pharmaceutical Society of Health-System Pharmacists (ASHP) publishes Care for Patients with Diabetes, Pharmacy-Based Lipid a directory of ASHP-accredited residency programs. The Management, OTC Advisor: Advancing Patient Self- American College of Clinical Pharmacy (ACCP) publishes Care, and Delivering Medication Therapy Management a directory of residency and fellowship programs offered Services in the Community). Pharmacists who success- by members of the ACCP. The APhA provides a searchable fully complete a postgraduate certificate program receive on-line community pharmacy residency locator directory. a certificate documenting successful completion of the A residency is defined as an “organized, directed, post- graduate training program in a defined area of pharmacy practice”8 (Table 1-3). Residencies provide pharmacists Box 1-3 Portfolio Requirements for Added with 1 to 2 years of supervised experience in practice Qualifications in Cardiology and management activities. Postgraduate year 1 (PGY- 1) residency programs train generalists; postgraduate Letter requesting portfolio review year 2 (PGY-2) residency programs train pharmacists in Detailed summary of each of the following elements: a specialty patient care area. Residents generally gain Specific and current professional responsibilities experience by providing a variety of inpatient and out- Bibliography of professional publications patient pharmacy services under the supervision of Past (within last 7 years) and present research and other one or more preceptors. Most residencies are based in scholarly activities hospitals; however, increased interest in community Past (within last 7 years) and current activities in pharmacy and ambulatory care residencies has resulted didactic or clerkship, residency, or fellowship in the creation of an increasing number of community education of health care professionals in pharmacy and ambulatory care residency programs. The cardiovascular pharmacotherapy ASHP accredits residency programs, but there are many Current memberships in professional organization nonaccredited residency programs. related to cardiology A fellowship is a highly individualized program Special or unique training or professional development designed to prepare the pharmacist to become an inde- programs pendent researcher.8 Fellows spend approximately 80% Professional awards, honors, or special achievements of their time in research-related activities. Currently no related to cardiovascular pharmacotherapy mechanism for accreditation of fellowship programs is Current curriculum vitae available. However, the ACCP Fellowship Review Com- From Board of Pharmacy Specialties: Current Specialties. Available at: http:// mittee conducts a voluntary peer review of fellowship www.bpsweb.org/specialties/specialties.cfm. Accessed October 12, 2009. programs. As of 2009, 17 fellowship programs were Table 1-2 Examples of Multidisciplinary Credentials Specialty Credentialing Organization Title Acronym Anticoagulation National Certification Board for Anticoagulation Certified Anticoagulation Care CACP Providers Provider Asthma National Asthma Educator Certification Board Certified Asthma Educator AE-C Diabetes National Certification Board for Diabetic Educators Certified Diabetic Educator CDE Lipidology Accreditation Council for Lipidology Clinical Lipid Specialist CLS Pain American Academy of Pain Management Credentialed Pain Practitioner CPP Toxicology American Board of Applied Toxicology Diplomate of the American Board of DABAT Applied Toxicology
Description: